Oral psilocybin undergoes first-pass metabolism , which can vary significantly between individuals and can be altered by drugs such as GLP-1 agonists
You are not making the peptide dangerous, and you are not wasting the whole protocol over one night
Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetes
Others have read about microdosing approaches for related medications like tirzepatide and wonder if the same principle applies to semaglutide
We will cover the following causes in detail: slowed digestive motility, reduced food intake, low fiber consumption, dehydration, electrolyte imbalance, and physical inactivity